
ADS032 (ADS-032) is the first, reversible and stable dual NLRP1 and NLRP3 inflammasome ингибитор, inhibits nigericin-induced NLRP3-induced IL-1β secretion from LPS-primed iBMDMs с IC50 of 30 uM.
ADS032 (ADS-032) is the first, reversible and stable dual NLRP1 and NLRP3 inflammasome inhibitor, inhibits nigericin-induced NLRP3-induced IL-1β secretion from LPS-primed iBMDMs with IC50 of 30 uM.
Только для научно-исследовательского применения. Не предназначено для использования у пациентов или в качестве лекарственного средства.